Starpharma Holdings Limited (ASX:SPL)
Australia · Delayed Price · Currency is AUD
0.4100
+0.0100 (2.50%)
Mar 11, 2026, 4:10 PM AEST
Revenue by Segment
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | Jun '19 Jun 30, 2019 | Jun '18 Jun 30, 2018 | Jun '17 Jun 30, 2017 | Jun '16 Jun 30, 2016 |
|---|
Discovery, Development and Commercialisation of Dendrimers | 5.85M | 9.76M | 4.34M | 5.16M | 3.49M | | | | | |
Discovery, Development and Commercialisation of Dendrimers Growth | -40.04% | 124.64% | -15.87% | 48.04% | -50.99% | | | | | |
| 5.85M | 9.76M | 4.34M | 5.16M | 3.49M | | | | | |
| -40.04% | 124.64% | -15.87% | 48.04% | -50.99% | | | | | |
Source: S&P Global Market Intelligence.
